Vanguard Group
ONCR

Vanguard Group’s Oncorus, Inc. ONCR Stock Holding History

Vanguard Group’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-475,345
Closed -$164K – 4587
2023
Q1 		$164K Sell
475,345
-20,568
-4% -$7.68K ﹤0.01% 4345
2022
Q4 		$126K Sell
495,913
-401
-0.1% -$228 ﹤0.01% 4367
2022
Q3 		$422K Sell
496,314
-56,326
-10% -$72.2K ﹤0.01% 4259
2022
Q2 		$696K Sell
552,640
-33,970
-6% -$46.1K ﹤0.01% 4199
2022
Q1 		$1.04M Sell
586,610
-324,240
-36% -$908K ﹤0.01% 4191
2021
Q4 		$4.8M Buy
910,850
+137,894
+18% +$1.07M ﹤0.01% 3636
2021
Q3 		$7.22M Buy
772,956
+109,287
+16% +$1.25M ﹤0.01% 3431
2021
Q2 		$9.16M Buy
663,669
+208,980
+46% +$3.23M ﹤0.01% 3253
2021
Q1 		$6.33M Buy
454,689
+158,441
+53% +$3.28M ﹤0.01% 3402
2020
Q4 		$9.58M Buy
+296,248
New +$6.86M ﹤0.01% 3016

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $328M AUM 19.81% 1-Year Est. Return